| Literature DB >> 25342963 |
Marta E Lichawska1, Kazimiera H Bodek2, Julia Jezierska3, Aleksander Kufelnicki1.
Abstract
BACKGROUND: Chitosan, a non-toxic, biodegradable and biocompatible polysaccharide has attained great interest in pharmaceutical applications, as versatile drug delivery agent. Chitosan has been already shown to serve as vehicle for sustained drug release by chitosan-vanadium(IV) complex from a chitosan gel matrix. Therefore, chitosan gel proved to retain vanadium and preserve its insulin-mimetic efficacy. Nevertheless, there is a lack of reports concerning complexing equilibria in aqueous solution, in particular when using the more advantageous microcrystalline form of chitosan (MCCh). Microcrystalline chitosan shows a number of valuable features as compared with unmodified chitosan.Entities:
Keywords: Biomaterial; Equilibria in aqueous solution; Metal-polymer complexes; Microcrystalline chitosan; Vanadium (IV)
Year: 2014 PMID: 25342963 PMCID: PMC4173100 DOI: 10.1186/s13065-014-0050-7
Source DB: PubMed Journal: Chem Cent J ISSN: 1752-153X Impact factor: 4.215
Figure 1Structure of neutral chitosan (R = −NH , R’ = −NHOC-CH . In chitosan R predominates, in chitin every substituent is R’).
Figure 2Titration of the H - VO(IV) – MCCh (DD = 0.977) system at various ligand to metal ratio. CMCCh (mol L−1) = 7.0 × 10−3. The value of base equivalent a = −0.1 corresponds to HNO3 in excess as related to ligand.
Figure 3Titration curves (presented by square points) and species distribution of the complexes formed in H - VO(IV) – MCCh (DD = 0.977) system. CMCCh (mol L−1) = 7.0 × 10−3. Ligand to metal ratio a) 2:1, b) 5:1, c) 8:1, d) 10:1. Dotted points correspond to the pH range of visible precipitation.
Figure 4Simplified coordination scheme of L = MCCh to M = oxovanadium(IV) at neutral pH: a) MLH , b) ML H .
Cumulative stability constants log of the VO(IV) - MCCh complexes
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| 79.8% | 2:1 | −0.39 (5) | −0.68 ( | −4.48 (23) | −7.64 (6) | 2.53-7.34 |
| −0.26 (5) | ||||||
| −4.18 (24) | ||||||
| 5:1 | −0.82 ( | −7.81 (16) | ||||
| −0.80 (4) | ||||||
| −7.59 (8) | ||||||
| 8:1 | −0.90 (5) | −8.11 (10) | ||||
| −0.87 (4) | ||||||
| −7.43 (10) | ||||||
| 10:1 | −0.99 (6) | −7.83 (26) | ||||
| −0.98 (6) | ||||||
| −8.06 (11) | ||||||
| 97.7% | 2:1 | −0.53 (4) | −0.68 ( | −4.67 (21) | −5.38 (7) | 3.18-7.38 |
| −5.72 (29) | ||||||
| −0.56 ( | ||||||
| 5:1 | −0.71 (4) | −4.41 (9) | ||||
| −0.68 (4) | −4.45 (9) | |||||
| 8:1 | −0.68 (4) | −4.95 (10) | ||||
| −4.45 (9) | ||||||
| −0.88 (6) | ||||||
| 10:1 | −1.40 ( | −6.76 (6) | ||||
| −1.29 (8) | ||||||
| −5.69 (14) |
arefer to the general reaction: m(VO2 +) + lL + hH ⇌ (VO)LH 2.
bresults from individual titrations.
cresults from comprehensive files of all titrations.
T = 25.0°C, I = 0.1 mol L−1 (KNO3). Standard deviations in parentheses. C L = total concentration of ligand; C M = total concentration of VO2+.
Figure 5FTIR spectra obtained in thin polymer films of a) pure MCCh (DD 79.8%) and b) MCCh in presence of VO ions at various pH. Comparative spectrum for VO2+ taken in KBr pellets.
Figure 6EPR spectra of aqueous frozen solutions containing VOSO and chitosan as a function of pH together with the spectrum obtained (VO sim) by computer simulation of the experimental spectrum of water solution of VOSO .